Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan.

Ítems similars

• Low-level resistance to camptothecin in a human small-cell lung cancer cell line without reduction in DNA topoisomerase I or drug-induced cleavable complex formation.
  per: Sorensen, M., et al.
  Publicat: (1998)
• In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.
  per: Jensen, P. B., et al.
  Publicat: (1997)
• Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer.
  per: Kreisholt, J., et al.
  Publicat: (1998)
• Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells
  per: Jensen, Lars H, et al.
  Publicat: (2004)
• Reduced topoisomerase II activity in multidrug-resistant human non-small cell lung cancer cell lines.
  per: Eijdems, E. W., et al.
  Publicat: (1995)